Sunday, November 17, 2024
HomeIndustriesHealthcare

Healthcare

RegeneRx Partner Signs LOI with Global Ophthalmology CRO for Two Phase 3 Clinical Trials in Neurotrophic Keratitis

RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair, and regeneration, is reporting today that its U.S. joint venture (JV)...

Medicare Extends Coverage of Natera’s Signatera MRD Test to Muscle Invasive Bladder Cancer

Natera, Inc., a global leader in cell-free DNA testing, announced that it has received written confirmation from the CMS Molecular Diagnostics Services Program (MolDX)...

Retia Medical Raises $15 Million to Accelerate Commercialization of the Argos Hemodynamic Monitor

Retia Medical, an innovator in advanced hemodynamic monitoring, announced that it has secured $15 million in Series B funding. The financing round was led...

DuraStat Receives Vizient Innovative Technology Contract for Dural Repair Device

DuraStat LLC, a medical device company innovating in the area of surgical tissue closure, announced it has received an Innovative Technology contract from Vizient,...

Broncus Completed Surgeries on the First Group of Patients Using Its Intervapor, the Thermal Vapor Treatment System

Broncus Medical has completed surgeries on the first group of patients using its InterVapor(including InterVapor Generator and InterVapor Catheter, the "InterVapor®"), after it was...
0FansLike
0FollowersFollow
spot_img

Hot Topics